Argentina once again exports bovine embryos "in vivo" to the European Union

Argentina once again exports bovine embryos "in vivo" to the European Union

The operation, which had been suspended by the EU in 2021, was reopened after negotiations between the Bioeconomy Secretariat, SENASA and the Foreign Ministry. Buenos Aires - The National Agri-Food Health and Quality Service (SENASA) reports that, after three years, Argentina will once again export to the European Union (EU) bovine embryos collected "in vivo" from areas free of foot-and-mouth disease with vaccination. This is an operation that had been discontinued in 2021 because that year the EU modified its regulatory package and established that bovine embryos collected "in vivo" after April 21, 2021 must come exclusively from areas free of foot-and-mouth disease. without vaccination. Following Argentina's claims for the closure of a market without health reasons and the negotiations of the Bioeconomy Secretariat, SENASA and the Agricultural Department of the Argentine embassy to the EU, Implementing Regulation 351/2024 of the Commission of the January 17, 2024 and regulation Re. UE 403/21 was modified. The regulation incorporates the new model of International Veterinary Certificate (CVI) for the export of bovine embryos obtained "in vivo" and in vitro destined for the EU collected after April 21, 2021, identified as BOV-OOCYTES-EMB -A-ENTRY (Available Here)

This certificate is used to send embryos collected in vivo from donors vaccinated against Foot and Mouth Disease. When it comes to in vitro embryos, these must be obtained exclusively from donors not vaccinated against this disease. In both cases, the requirement of previous years is maintained, which establishes that the semen used for insemination must be imported from countries authorized by the EU. Information on the export of goods of animal origin is available on the official SENASA website, where you can find out the health requirements of each destination.

inngeniar